From: Epidemiology and microbiology of fracture-related infection: a multicenter study in Northeast China
Antimicrobial | MRSA (n = 42) | MSSA (n = 124) | ||||
---|---|---|---|---|---|---|
R (%) | I (%) | S (%) | R (%) | I (%) | S (%) | |
PEN | 100.0 | 0 | 0 | 95.2 | 0 | 4.8 |
OXA | 100.0 | 0 | 0 | 0 | 0 | 100.0 |
AMC | 100.0 | 0 | 0 | 0 | 0 | 100.0 |
CRO | 100.0 | 0 | 0 | 0 | 00 | 100.0 |
GEN | 33.3 | 4.8 | 61.9 | 21.0 | 0 | 79.0 |
RIF | 14.3 | 0 | 85.7 | 0 | 0 | 100.0 |
CIP | 19.0 | 9.5 | 71.4 | 14.5 | 21.0 | 64.5 |
LVX | 19.0 | 4.8 | 76.2 | 12.9 | 0 | 87.1 |
MFX | 19.0 | 0 | 81.0 | 12.9 | 1.6 | 85.5 |
SXT | 14.3 | 0 | 85.7 | 1.6 | 0 | 98.4 |
CLI | 81.0 | 0 | 19.0 | 41.9 | 3.2 | 54.9 |
DAP | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
ERY | 85.7 | 4.8 | 9.5 | 64.5 | 1.6 | 33.9 |
LNZ | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
VAN | 0 | 0 | 100.0 | 0 | 0 | 100.0 |
QDA | 14.3 | 0 | 85.7 | 0 | 0 | 100.0 |
TCY | 38.1 | 4.8 | 57.1 | 8.1 | 3.2 | 88.7 |